NasdaqCM - Nasdaq Real Time Price USD

Citius Oncology, Inc. (CTOR)

0.8755
-0.0145
(-1.63%)
At close: May 21 at 4:00:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
Total Revenue
0
0
0
0
Operating Expense
25,164.0750
20,572.7470
12,121.2410
4,856.5990
Operating Income
-25,164.0750
-20,572.7470
-12,121.2410
-4,856.5990
Pretax Income
-25,164.0750
-20,572.7470
-12,121.2410
-4,856.5990
Tax Provision
816.4800
576
576
576
Net Income Common Stockholders
-25,980.5550
-21,148.7470
-12,697.2410
-5,432.5990
Diluted NI Available to Com Stockholders
-25,980.5550
-21,148.7470
-12,697.2410
-5,432.5990
Basic EPS
-0.38
-0.31
-0.18
-0.08
Diluted EPS
-0.38
-0.31
-0.18
-0.08
Basic Average Shares
71,552.4020
68,053.6070
71,239.8000
71,239.8000
Diluted Average Shares
71,552.4020
68,053.6070
71,239.8000
71,239.8000
Total Expenses
25,164.0750
20,572.7470
12,121.2410
4,856.5990
Net Income from Continuing & Discontinued Operation
-25,980.5550
-21,148.7470
-12,697.2410
-5,432.5990
Normalized Income
-25,980.5550
-21,148.7470
-12,697.2410
-5,432.5990
EBIT
-25,164.0750
-20,572.7470
-12,121.2410
-4,856.5990
EBITDA
-25,164.0750
-20,572.7470
-12,121.2410
-4,856.5990
Net Income from Continuing Operation Net Minority Interest
-25,980.5550
-21,148.7470
-12,697.2410
-5,432.5990
Normalized EBITDA
-25,164.0750
-20,572.7470
-12,121.2410
-4,856.5990
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
0
0
0
0
9/30/2022 - 12/8/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TXMD TherapeuticsMD, Inc.
1.4600
-2.01%
 
ZYBT Zhengye Biotechnology Holding Limited
8.89
+14.71%
 
GELS Gelteq Limited
1.8200
+6.43%
 
MVMDF Mountain Valley MD Holdings Inc.
0.0217
+24.71%
 
MVMD.CN Mountain Valley MD Holdings Inc.
0.0250
0.00%
 
RMTI Rockwell Medical, Inc.
0.9957
-6.94%
 
AKAN Akanda Corp.
1.2500
+0.81%
 
UPC Universe Pharmaceuticals INC
5.58
-7.77%
 
PRFX PainReform Ltd.
1.8700
-4.10%
 
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.1861
-7.23%